ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Tian Wenzhi, was filed 14 May 2026.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B: what insiders have been doing
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B has a thin disclosure history in our data (latest filing: 14 May 2026). New filings will appear here as soon as they are published. Source: insider filings from HKEX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -14.8%Entry HK$3.52 · Close 22 Oct 2026 HK$3.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 50,000 shares@ HK$3.870.011% mcap100.0% of flowShareXHKGHKEX:DA20260513E00577Canonical exit: 11 Aug 2026 (T+90)
1 of 1 declaration
About ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a company focused on developing innovative treatments in oncology. It is listed on the XHKG market.
